T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Hubbell
HUBB
$27.1B
| $7.19M | ﹤0.01% |
67,855
-34,295
| -34% | -$3.28M |
|
|
HBMD
1327
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $7.07M | ﹤0.01% |
587,356
+9,046
| +2% | +$112K |
|
1328
Lantheus
LNTH
$6.57B
| $6.99M | ﹤0.01% |
3,696,371
-12,640
| -0.3% | -$28K |
|
1329
Standex International
SXI
$4B
| $6.98M | ﹤0.01% |
89,730
+5,900
| +7% | +$428K |
|
1330
Markel Group
MKL
$22.8B
| $6.83M | ﹤0.01% |
7,660
+1,353
| +21% | +$1.16M |
|
1331
Helix Energy Solutions
HLX
$1.49B
| $6.74M | ﹤0.01% |
1,202,808
-2,161,290
| -64% | -$9.12M |
|
1332
Paylocity
PCTY
$7.73B
| $6.72M | ﹤0.01% |
205,340
-680
| -0.3% | -$21.2K |
|
1333
WisdomTree
WT
$3.44B
| $6.68M | ﹤0.01% |
584,398
+9,668
| +2% | +$116K |
|
|
QVCGA
1334
DELISTED
QVC Group Inc Series A
QVCGA
| $6.67M | ﹤0.01% |
5,440
+160
| +3% | +$195K |
|
|
WFBI
1335
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $6.66M | ﹤0.01% |
320,166
+142,926
| +81% | +$2.92M |
|
|
AIMT
1336
DELISTED
Aimmune Therapeutics
AIMT
| $6.62M | ﹤0.01% |
488,398
-2,050
| -0.4% | -$32K |
|
1337
Nektar Therapeutics
NKTR
$2.57B
| $6.58M | ﹤0.01% |
31,927
+3,447
| +12% | +$662K |
|
|
JPM.WS
1338
DELISTED
JPMorgan Chase
JPM.WS
| $6.54M | ﹤0.01% |
369,300
| – | – |
|
1339
Ryder
R
$10.1B
| $6.51M | ﹤0.01% |
100,575
+1,900
| +2% | +$108K |
|
|
ARC
1340
DELISTED
ARC Document Solutions, Inc.
ARC
| $6.51M | ﹤0.01% |
1,446,221
+34,930
| +2% | +$131K |
|
|
CSRA
1341
DELISTED
CSRA Inc.
CSRA
| $6.5M | ﹤0.01% |
241,629
-2,175
| -0.9% | -$56.9K |
|
1342
KT
KT
$8.83B
| $6.47M | ﹤0.01% |
482,400
| – | – |
|
1343
Copa Holdings
CPA
$6.14B
| $6.45M | ﹤0.01% |
95,168
+3,500
| +4% | +$196K |
|
|
SWN
1344
DELISTED
Southwestern Energy Company
SWN
| $6.43M | ﹤0.01% |
797,420
+158,550
| +25% | +$1.22M |
|
1345
Insulet
PODD
$10.1B
| $6.36M | ﹤0.01% |
191,821
-188,540
| -50% | -$5.92M |
|
1346
Eagle Materials
EXP
$6.47B
| $6.3M | ﹤0.01% |
89,875
-98,630
| -52% | -$5.74M |
|
|
CTRL
1347
DELISTED
Control4 Corporation
CTRL
| $6.3M | ﹤0.01% |
790,892
+62,300
| +9% | +$463K |
|
1348
Genpact
G
$5.7B
| $6.27M | ﹤0.01% |
230,731
+15,209
| +7% | +$385K |
|
|
NIHD
1349
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $6.24M | ﹤0.01% |
1,128,812
| – | – |
|
|
FL
1350
DELISTED
Foot Locker
FL
| $6.24M | ﹤0.01% |
96,739
+7,795
| +9% | +$506K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.